Literature DB >> 21139216

Crystallization and preliminary X-ray crystallographic analysis of zebrafish prototype galectin Drgal1-L2.

Stacy A Scott1, Matthew O Cozier, Pauline D I Dubar, Manasa Ramakrishna, Ken Scott, Helen Blanchard.   

Abstract

Zebrafish (Danio rerio) are an important developmental and embryological model given the optical clarity of the embryos and larvae, which permits real-time viewing of developing pathologies. More recently, a broader scope for these vertebrates to model a range of human diseases, including some cancers, has been indicated. Zebrafish Drgal1-L2 has been identified as an orthologue of mammalian galectin-1, which is is a carbohydrate-binding protein that exhibits β-galactoside-binding specificity and which is overexpressed by many aggressive human cancers. This study describes the cloning, expression in Escherichia coli, purification and crystallization of recombinant Drgal1-L2 protein in the presence of lactose (ligand). X-ray diffraction data from these novel crystals of zebrafish Drgal1-L2 were collected to a resolution of 1.5 Å using a synchrotron-radiation source, enabling their characterization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139216      PMCID: PMC2998375          DOI: 10.1107/S1744309110042272

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  26 in total

Review 1.  Expression of galectins in cancer: a critical review.

Authors:  Frédéric van den Brûle; Stèphane Califice; Vincent Castronovo
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Visualization of embryonic lymphangiogenesis advances the use of the zebrafish model for research in cancer and lymphatic pathologies.

Authors:  Maria Vega Flores; Christopher J Hall; Kathryn E Crosier; Philip S Crosier
Journal:  Dev Dyn       Date:  2010-07       Impact factor: 3.780

3.  Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides.

Authors:  Y Bourne; B Bolgiano; D I Liao; G Strecker; P Cantau; O Herzberg; T Feizi; C Cambillau
Journal:  Nat Struct Biol       Date:  1994-12

Review 4.  Galectins. Structure and function of a large family of animal lectins.

Authors:  S H Barondes; D N Cooper; M A Gitt; H Leffler
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

Review 5.  Galectin-1: a small protein with major functions.

Authors:  Isabelle Camby; Marie Le Mercier; Florence Lefranc; Robert Kiss
Journal:  Glycobiology       Date:  2006-07-13       Impact factor: 4.313

Review 6.  From Zebrafish to human: modular medical models.

Authors:  Jordan T Shin; Mark C Fishman
Journal:  Annu Rev Genomics Hum Genet       Date:  2002-04-15       Impact factor: 8.929

7.  Crystallization and preliminary crystallographic analysis of recombinant human galectin-1.

Authors:  Stacy A Scott; Ken Scott; Helen Blanchard
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-10-24

Review 8.  Galectin-1: a bifunctional regulator of cellular proliferation.

Authors:  Ken Scott; Cristina Weinberg
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

9.  Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.

Authors:  S H Hsieh; N W Ying; M H Wu; W F Chiang; C L Hsu; T Y Wong; Y T Jin; T M Hong; Y L Chen
Journal:  Oncogene       Date:  2008-01-28       Impact factor: 9.867

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  2 in total

1.  Crystals on the cover 2012.

Authors:  Howard Einspahr; Manfred S Weiss
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

2.  Structure of the zebrafish galectin-1-L2 and model of its interaction with the infectious hematopoietic necrosis virus (IHNV) envelope glycoprotein.

Authors:  Anita Ghosh; Aditi Banerjee; L Mario Amzel; Gerardo R Vasta; Mario A Bianchet
Journal:  Glycobiology       Date:  2019-05-01       Impact factor: 5.954

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.